News

Mometasone furoate

  • Author:Hubei Ocean Biotech Co,.LTd
  • Source:www.oceanchinachem.com
  • Release on :2016-06-09

Mometasone furoate is used in the treatment of inflammatory skin disorders (such as eczema and psoriasis) (topical form), allergic rhinitis (such as hay fever) (topical form), asthma (inhalation form)for patients unresponsive to less potent corticosteroids, and penile phimosis. In terms of steroid strength, it is more potent than hydrocortisone, and less potent than dexamethasone.

There is some low quality evidence suggesting the use of mometasone for symptomatic improvement in children with adenoid hypertrophy.

Mometasone is indicated for the alleviation of inflammatory and pruritic manifestations (with stinging and itching) of dermatosis which respond to treatment with glucocorticoides such as psoriasis and atopic dermatitis (affection dermic chronic, characterized by the apparition of squamous eruptions, accompanied by itching).

Nasal mometasone is employed in adults (including the elderly) and children over 2 years, diminishing the symptoms such as hayfever (seasonal allergic rhinitis) and other allergies (perennial rhinitis), including nasal congestion, discharge, pruritus and sneezing.[7] Mometasone can be used two to four weeks before pollen season, reducing the severity of symptoms. It is also indicated for the treatment of nasal polyps and symptoms associated with including congestion and hyposmia in adult patients over the age of 18. It can also produce nasal drip, sensation of tickling in the throat and loss of the sense of taste and smell.

HBOcean Biotech Co., Ltd is a leading professional enterprise focus on  pharmaceutical products and APIs, with integrating production and trade for global valued customer with our superior quality and reliable cooperation. Should you have any interest in our products, welcome to take view at our site or contact us for more details.